SEC Form 4 · accession 0001209191-18-035596
AKCEA THERAPEUTICS, INC. · AKCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandford D Smith
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001662524
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $23.46 | Jun 1, 2018 | A | 26,400 | A | — | May 31, 2028 | Common Stock | 26,400 | 26,400 | D |
Explanation of responses
- F1The shares vest over a four year period in equal annual installments beginning on June 1, 2018.